2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y(12) Receptor Antagonists in the Asia-Pacific Region

The unique characteristics of patients with acute coronary syndrome in the Asia-Pacific region mean that international guidelines on the use of dual antiplatelet therapy (DAPT) cannot be routinely applied to these populations. Newer generation P2Y(12) inhibitors (i.e. ticagrelor and prasugrel) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jack WC, Chew, Derek P, Abdul Kader, Muhamad Ali SK, Ako, Junya, Bahl, Vinay K, Chan, Mark, Park, Kyung Woo, Chandra, Praveen, Hsieh, I-Chang, Huan, Do Quang, Johar, Sofian, Juzar, Dafsah Arifa, Kim, Byeong-Keuk, Lee, Cheol Whan, Lee, Michael Kang-Yin, Li, Yi-Heng, Almahmeed, Wael, Sison, Eric Oliver, Tan, Doreen, Wang, Yu-Chen, Yeh, Shiuan Jong, Montalescot, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
APSC Consensus Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941380/
https://www.ncbi.nlm.nih.gov/pubmed/33708263
http://dx.doi.org/10.15420/ecr.2020.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941380/
https://www.ncbi.nlm.nih.gov/pubmed/33708263
http://dx.doi.org/10.15420/ecr.2020.40

Ejemplares similares